Title:
増殖因子を使用する炎症性腸疾患の処置
Document Type and Number:
Japanese Patent JP2004537267
Kind Code:
A
Abstract:
The present invention is based upon methods of treating inflammatory conditions in the intestinal tract of mammals using growth factor related polypeptides. Methods of using fibroblast growth factor-CX (FGF-CX) polynucleotide sequences and the FGF-CX polypeptides encoded by such nucleic acid sequences, or variants, fragments and homologs thereof, are claimed in the invention. Similarly, methods of using FCTRX polynucleotide sequences and the FCTRX polypeptides encoded by such nucleic acid sequences, or variants, fragments and homologs thereof, alone or in combination, are also claimed in the invention. FCTRX collectively refers to any of six variant FCTRX sequences, variously designated FCTR1, FCTR2, FCTR3, FCTR4, FCTR5 and FCTR6.
Inventors:
Jeffers, michael
Simquets, Richard A.
Playaga, Sudhildas
Boldog, Feren El.
Yang, major
Burgess, Catherine Yi.
Fernandez, Elmar Earl.
Littman, Bee.
Simquets, Juliet Bee.
La Rochelle, William Jay.
Riekenstein, Henry S.
Simquets, Richard A.
Playaga, Sudhildas
Boldog, Feren El.
Yang, major
Burgess, Catherine Yi.
Fernandez, Elmar Earl.
Littman, Bee.
Simquets, Juliet Bee.
La Rochelle, William Jay.
Riekenstein, Henry S.
Application Number:
JP2002559050A
Publication Date:
December 16, 2004
Filing Date:
November 06, 2001
Export Citation:
Assignee:
Curagen Corporation
International Classes:
A61K38/22; A61P1/04; A61P7/00; A61P7/06; A61P17/14; A61P29/00; C07K14/47; C07K14/49; C12N5/10; C07K14/50; C07K14/51; C07K14/52; A61K38/00; (IPC1-7): C12N5/10; A61K38/22; A61P1/04; A61P7/00; A61P7/06; A61P17/14; A61P29/00
Attorney, Agent or Firm:
Takeshi Oshio
Previous Patent: タンパク質、それらをコードするポリヌクレオチド、およびそれらの使用...
Next Patent: 腫瘍抑制、腫瘍復帰変異、アポトーシスおよび／またはウイルス耐性の現...
Next Patent: 腫瘍抑制、腫瘍復帰変異、アポトーシスおよび／またはウイルス耐性の現...